<?xml version="1.0" encoding="UTF-8"?>
<p id="Par28">For the first time, we have detected that the age peak of HFRS patients is slightly getting older. It is assumed that more and more young people trend to migrate into urban cities resulting in low frequency of contact with virus-carrying rodents. While, adult male farmers are still the key population of HFRS disease promptting that these people should be primary objects for the immunization programs. So far, the inactivated vaccines yielded from cultured cells or rodent brain has been licensed for use in humans in China [
 <xref ref-type="bibr" rid="CR24">24</xref>] and the immunization program was executed in northeastern cities, Tangshan and Qinhuangdao since 2008. While the immune protective efficiency of these vaccines was still unclear and needs some further observation. In addition, some other classical or advanced molecular vaccine approaches, including DNA vaccines and attenuated live vaccines are still in pre- or clinical stages for further evaluations [
 <xref ref-type="bibr" rid="CR6">6</xref>, 
 <xref ref-type="bibr" rid="CR24">24</xref>].
</p>
